Articles that mention Allergan -BoardProspects

Allergan

0 Comments Leave a Comment

1-15 of 45 1 2 3 »
1. Mentioned In 45 Articles
2. As Ackman Hunts Blockbuster Deal, He Counts on Big Backers
  
  Explore Yahoo! Finance Nov 18 2020 BoardNews
  
  ... best known for his big wins as an activist shareholder in railroad operator Canadian Pacific and Botox maker Allergan, though he also suffered deep losses at pharmaceutical company Valeant and nutritional supplements ma...
  Read Full Article
  
  Comment
  
  Mentions: Investment Management Hedge Fund
3. 20 Highest-Paid Biopharma CEOs
  
  Explore Pharma News Sep 18 2020 BoardNews
  
  ... might be the most lucrative in pharma history; now CEO at Allergan ($AGN), neé Actavis, which just swallowed Allergan in a $66 billion deal and adopted its name. His compensation report barely trailed Leiden's. We'll le...
  Read Full Article
  
  Comment
  
  Mentions: Twitter stock options Vertex
4. NeoGenomics (NEO) Adds Rachel A. Stahler and Michael A. Kelly to Board
  
  Explore StreetInsider.com Jul 20 2020 BoardMoves
  
  ...rience in the pharmaceutical industry. Previously, Ms. Stahler held the roles of Chief Information Officer of Allergan, Chief Information and Digital Officer for Syneos Health, Chief Information Officer at Optimer Pharma...
  Read Full Article
  
  Comment
  
  Mentions: Human Resources Leadership Independent Director
5. IVERIC Bio Announces the Addition of Mark S. Blumenkranz, M.D., M.M.S., to its Board of Directors
  
  Explore gurufocus.com Jul 16 2020 BoardMoves
  
  ...erve on their Boards. In the past he served as an independent Director at Oculex Pharmaceuticals (acquired by Allergan), and Presbia.Dr. Blumenkranz has a longstanding interest and expertise in university corporate techn...
  Read Full Article
  
  Comment
  
  Mentions: Nasdaq Executive Chairman Stanford University
6. Adding Women to Corporate Boards Improves Decisions About Medical Product Safety
  
  Explore Phys.Org Jun 11 2020 BoardNews
  
  ...r problems. The consequences of failing to quickly recall faulty medical products can be deadly. For example, Allergan reportedly waited years before finally recalling breast implants in 2019 despite learning the implant...
  Read Full Article
  
  Comment
  
  Mentions: acquisition Women Female
7. The Impact Of The Coronavirus Crisis On Mergers And Acquisitions
  
  Explore forbes.com Apr 17 2020 BoardBlogs
  
  ...s, including a generics merger between Pfizer's Upjohn unit and Mylan, and a $63 billion merger of AbbVie and Allergan, have been delayed or postponed as a result of these regulatory developments. For sensitive transacti...
  Read Full Article
  
  Comment
  
  Mentions: Mergers and Acquisitions Investment Delaware
8. Cytonus appoints Allergan executive Manisha Narasimhan, Ph.D. to its Board of Directors
  
  Explore Press Release Distribution Mar 10 2020 BoardMoves
  
  Cytonus Therapeutics Inc. today announced that Manisha Narasimhan, Ph.D. has joined Cytonus Board of Directors...
  Read Full Article
  
  Comment
  
  Mentions: Allergan Cytonus Therapeutics Inc. Manisha Narasimhan
9. Maze Therapeutics Appoints City Hill Founder, Jonathan Lim, MD, to its Board of Directors
  
  Explore businesswire.com Oct 23 2019 BoardMoves
  
  ...n 2018. He also previously served as chairman and co-founder of Bonti from 2015 until its 2018 acquisition by Allergan; chairman, chief executive officer and co-founder of Eclipse Therapeutics from 2011 to its 2012 acqui...
  Read Full Article
  
  Comment
  
  Mentions: acquisition Harvard Harvard University
10. Abbvie is Buying Botox-Maker Allergan in a $63 Billion Pharma Mega-Deal
  
  Explore Stock Market Data Today Jun 25 2019 BoardNews
  
  ...Allergan share. The offer represents a 45% premium to the closing price of Allergan's shares on Wednesday... Allergan shareholders will receive 0.8660 AbbVie shares and $120.30 in cash for each Allergan share that they ...
  Read Full Article
  
  Comment
  
  Mentions: Allergan Wall Street CEO
11. Teva CEO Kåre Schultz Nabs Whopping $33M in First Full Year at the Helm
  
  Explore Pharma News Apr 17 2019 BoardBlogs
  
  ...man, who departed after a series of costly missteps, not the least of which was a doomed $40.5 billion buy of Allergan’s generics unit. RELATED: Teva lures Lundbeck chief Schultz with $52M package that makes him among ph...
  Read Full Article
  
  Comment
  
  Mentions: Allergan CEO
12. Allergan (AGN) Says Proxy Advisory Firms ISS and Glass Lewis Support All its Board's Voting ...
  
  Explore StreetInsider.com Apr 15 2019 BoardNews
  
  Commenting on the ISS and Glass Lewis reports, Allergans Board of Directors said: We are pleased with the support we have received from both ...
  Read Full Article
  
  Comment
  
  Mentions: Proxy Advisory ISS Allergan
13. Here’s One Way to Tell if a Company is Overpaying its CEO
  
  Explore MarketWatch Apr 14 2019 BoardBlogs
  
  ...s. In 2014-15, for example, about 28%, or $16.5 million, of overall CEO pay of $58 million at the botox maker Allergan Inc. AGN, -0.06% was granted for meeting non-GAAP earnings targets — the company had a net loss in th...
  Read Full Article
  
  Comment
  
  Mentions: Management Equifax stock options
14. AbbVie Investors Agitate for Chair-CEO Split, Flagging Bonus Pay and Humira Hikes
  
  Explore Pharma News Apr 2 2019 BoardNews
  
  ...ble pricing of Humira,” Magaziner said. The call for an AbbVie leadership shakeup comes amid a proxy fight at Allergan that began when activist investor Appaloosa demanded a chairman-CEO split. The hedge fund has taken s...
  Read Full Article
  
  Comment
  
  Mentions: Mylan lawsuit Allergan
15. Hedge Fund Appaloosa Unimpressed by Allergan Board Promises
  
  Explore Channel NewsAsia Mar 25 2019 BoardNews
  
  ... Allergan since last year to separate the roles of CEO and chairman or potentially sell or merge the company. Allergan on Friday agreed to split its chairman and chief executive roles, but only at its next scheduled lead...
  Read Full Article
  
  Comment
  
  Mentions: Allergan Appaloosa Appaloosa LP
16. Starboard vs. Bristol-Myers Squibb: Who'll Win This Brewing Battle?
  
  Explore Fool.com Mar 20 2019 BoardBlogs
  
  ...rd, and Starboard pointed to the $66 billion merger between Actavis and Allergan. To make a long story short, Allergan shares have lost 50% of their value since the deal closed four years ago. Rather than take a huge ris...
  Read Full Article
  
  Comment
  
  Mentions: Management acquisition Nasdaq
17. 1-15 of 45 1 2 3 »